bioactive small molecule scm-198 (Cardiovascular Systems Inc)
90
Structured Review
Cardiovascular Systems Inc
bioactive small molecule scm-198
Bioactive Small Molecule Scm 198, supplied by Cardiovascular Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bioactive+small+molecule+scm-198/bioactive+small+molecule+scm+198/pmc11649909-33-6-11
Average 90 stars, based on 1 article reviews
Bioactive Small Molecule Scm 198, supplied by Cardiovascular Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bioactive+small+molecule+scm-198/bioactive+small+molecule+scm+198/pmc11649909-33-6-11
Average 90 stars, based on 1 article reviews
bioactive small molecule scm-198 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Binding Assay:Article Title: Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure Article Snippet: However, despite years of research on Conjugation Assay:Article Title: Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure Article Snippet: However, despite years of research on Incubation:Article Title: Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure Article Snippet: However, despite years of research on CCK-8 Assay:Article Title: Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure Article Snippet: However, despite years of research on Control:Article Title: Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure Article Snippet: However, despite years of research on Fluorescence:Article Title: Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure Article Snippet: However, despite years of research on |